Alpelisib is a medication that belongs to a class of drugs known as PI3K inhibitors. It is used in the treatment of certain types of breast cancer that are hormone receptor-positive and HER2-negative. This medication works by blocking a specific protein in cancer cells that is involved in the growth and spread of the tumor.

Alpelisib is typically prescribed in combination with another medication called fulvestrant for postmenopausal women or men with advanced breast cancer that has progressed despite other treatments. It is important to follow your healthcare provider’s instructions carefully when taking alpelisib, as the dosage and duration of treatment may vary depending on your individual condition and response to the medication.

As with any medication, alpelisib may cause side effects. Common side effects of this drug include diarrhea, nausea, fatigue, rash, decreased appetite, and mouth sores. It is important to report any side effects to your healthcare provider so that they can be properly managed.

Before starting treatment with alpelisib, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. This will help ensure that alpelisib is safe and appropriate for you.

Overall, alpelisib is an important medication in the treatment of advanced breast cancer and has shown promising results in clinical trials. If you have been prescribed alpelisib, it is important to take it as directed and to communicate openly with your healthcare provider about any concerns or questions you may have.